Joel Cohen-Solal

Company: Abbvie

Job title: Pr. Research Scientist

Seminars:

Delve Into IgG and Fc Engineering, Specifically Focusing on Modulation of Antibodies interaction to FcgRIIB 11:00 am

Consequence of engagement of IgG Fc by the inhibition FcgRIIB expressed by immune cells, non-immune cells and cancer cells. Binding characteristics of IgG Fc engineered for modulation of FcgRIIB interaction. Highlight on pre-clinical studiesRead more

day: Day Two